Perspective Therapeutics Inc (CATX)
3.47
+0.47
(+15.67%)
USD |
NYAM |
Nov 22, 16:00
3.49
+0.02
(+0.58%)
After-Hours: 20:00
Perspective Therapeutics Cash from Financing (Quarterly): 0.628M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.628M |
| June 30, 2024 | 122.08M |
| March 31, 2024 | 166.33M |
| December 31, 2023 | 0.352M |
| September 30, 2023 | 0.001M |
| June 30, 2023 | 0.512M |
| March 31, 2023 | -0.08M |
| September 30, 2022 | 0.028M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.056M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.243M |
| March 31, 2021 | 55.98M |
| December 31, 2020 | 8.465M |
| September 30, 2020 | |
| June 30, 2020 | 0.874M |
| March 31, 2020 | 0.131M |
| December 31, 2019 | -0.011M |
| September 30, 2019 | |
| June 30, 2019 | 0.013M |
| March 31, 2019 | -0.009M |
| December 31, 2018 | -0.124M |
| September 30, 2018 | 7.494M |
| June 30, 2018 | 0.482M |
| Date | Value |
|---|---|
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.039M |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | -0.009M |
| September 30, 2016 | |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.003M |
| December 31, 2015 | -0.011M |
| September 30, 2015 | 0.047M |
| June 30, 2015 | 0.0796M |
| March 31, 2015 | 0.0004M |
| December 31, 2014 | -0.0106M |
| September 30, 2014 | 0.2157M |
| June 30, 2014 | 0.3858M |
| March 31, 2014 | 19.80M |
| December 31, 2013 | -0.0122M |
| September 30, 2013 | 3.281M |
| June 30, 2013 | 0.0018M |
| March 31, 2013 | 0.00 |
| December 31, 2012 | -0.007M |
| September 30, 2012 | 3.302M |
| June 30, 2012 | 0.7983M |
| March 31, 2012 | -0.0052M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.08M
Minimum
Mar 2023
166.33M
Maximum
Mar 2024
19.75M
Average
0.187M
Median
Cash from Financing (Quarterly) Benchmarks
| Plus Therapeutics Inc | 0.00 |
| Retractable Technologies Inc | -0.1343M |
| InfuSystems Holdings Inc | -6.752M |
| Xtant Medical Holdings Inc | 5.314M |
| Catheter Precision Inc | 4.02M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 3.366M |
| Cash from Investing (Quarterly) | -29.74M |
| Free Cash Flow | -40.58M |
| Free Cash Flow Per Share (Quarterly) | -0.373 |
| Free Cash Flow Yield | -21.77% |